RecruitingNCT05733091

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

Sponsor

M.D. Anderson Cancer Center

Enrollment

300 participants

Start Date

Dec 20, 2018

Study Type

OBSERVATIONAL

Conditions

Tumors

Summary

To learn about the symptoms and changes our patients experience while receiving treatment for sinonasal or nasopharyngeal cancer

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Previously untreated patients with or suspected to have sinonasal malignancy or nasopharyngeal malignancy diagnosis based on either outside pathology report or MD Anderson pathology report.
Age ≥ 18 years
Plan to obtain the majority of treatment at MDACC including surgery and radiotherapy
Ability to understand and willingness to sign written informed consent

Exclusion Criteria3

History of the previous solid or liquid malignancies, apart from skin cancers treated with local therapy.
Existing neurocognitive impairment that is not the result of sinonasal and nasopharyngeal cancers or is treatment.
Previous treatment for sinonasal or nasopharyngeal carcinomas, apart from biopsy.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALStandard of Care

Standard of care assessment of their function including pituitary hormone lab draws, audiogram hearing test, eye exam, teeth and jaw exam (in trismus clinic) and speech and swallowing evaluation

Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05733091

Related Trials

HP Pyruvate MRI in Cancers

NCT056974061 location

ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling

NCT043411817 locations